Haibin Zhou
University of Michigan
H-index: 20
North America-United States
Top articles of Haibin Zhou
Evaluation of a highly potent and selective STAT3 degrader as a new class of immunotherapy
Cancer Research
2024/3/22
Discovery of highly potent, selective and efficacious STAT3 PROTAC degraders capable of achieving complete tumor regression
Cancer Research
2024/3/22
Small molecule stat protein degraders
2023/5/25
Method of treating graft-versus-host disease
2023/5/4
STAT3 restrains dendritic cell function and tumor immunity
The Journal of Immunology
2023/5/1
Small molecule degraders of stat3
2023/3/16
Stat3 protein degraders
2022/6/16
Small molecule menin inhibitors
2021/11/18
Removal notice to" Resveratrol augments the canonical Wnt signaling pathway in promoting osteoblastic differentiation of multipotent mesenchymal cells"[YEXCR Volume 315, Issue …
Experimental cell research
2021/7/1
Haibin Zhou
H-Index: 16
Xi Li
H-Index: 6
Xiyu Zhang
H-Index: 15
Guimin Gao
H-Index: 12
Changshun Shao
H-Index: 33
Selective inhibition of cullin 3 neddylation through covalent targeting DCN1 protects mice from acetaminophen-induced liver toxicity
Nature Communications
2021/5/11
SD-91 as a potent and selective STAT3 degrader capable of achieving complete and long-lasting tumor regression
ACS Medicinal Chemistry Letters
2021/5/10
Haibin Zhou
H-Index: 16
Ruiting Li
H-Index: 6
Bo Wen
H-Index: 16
Mi Wang
H-Index: 11
Shaomeng Wang
H-Index: 52
Discovery of potent small-molecule inhibitors of MLL methyltransferase
ACS Medicinal Chemistry Letters
2020/5/14
Targeting DCN1-UBC12 protein-protein interaction for regulation of neddylation pathway
2020